fasting and tirzepatide Efficacy Safety of in Type 2 Diabetes and Obesity Management Day 3: Mounjaro (Tirzepatide –

Consider how timing and research inform your choices

CAP Code Section 15: Weight control and slimming Advertising Standards Authority

As geriatric medicine specialists, endocrinologists, and obesity medicine physicians have noted in growing public commentary, prescribing a powerful weight-loss drug to a 70-year-old patient carries a fundamentally different risk profile than prescribing the same drug to a 45-year-old with the same BMI

"SLU-PP-332" priced at less than $1/mg with no COA pricing this aggressive on a synthesized small molecule suggests cut product or an inert powder being sold under the SLU-PP-332 label

Avoid the inner thigh, back of the thigh, or areas very close to the knee or hip bone, as these regions have less predictable fat distribution or higher nerve concentration